Zim Laboratories (ZIMLA) Share Price rises 6.75% as stock trades near 52-week high
- October 7, 2026
- Posted by: Chaitanya Auti
- Category: News
Zim Laboratories Share Price is trading at Rs 150.15, up 6.75% from the previous close of Rs 140.65, and sits close to its 52-week high after touching Rs 154 during the day. The company’s market capitalisation stands at Rs 786.1 crore. According to latest Univest data, Zim Laboratories Ltd. (ZIMLA) is in focus because the price move places the stock near its yearly high without implying any company-specific trigger.
For readers tracking Zim Laboratories Share Price Today, the latest move shows a gap between the opening level of Rs 142.95 and the day’s low of Rs 140 before the price moved higher during the morning session. The latest Univest figures confirm the near 52-week-high event, while the available financial and sector data help frame the move in a broader market context. Zim Laboratories Stock News today therefore centres on verified price behaviour, valuation, and how the stock compares with peers in the Pharmaceuticals & Drugs segment.
Zim Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 150.15 |
| Previous Close | Rs 140.65 |
| Today's Move | +Rs 9.5 (+6.75%) |
| Open | Rs 142.95 |
| High | Rs 154 |
| Low | Rs 140 |
| Market Capitalisation | Rs 786.1 crore |
Zim Laboratories Ltd. (ZIMLA) traded at Rs 150.15 versus the previous close of Rs 140.65, a rise of 6.75%. The stock opened at Rs 142.95, reached a high of Rs 154 and touched a low of Rs 140.
Zim Laboratories Share Price Today is Rs 150.15 versus the previous close of Rs 140.65, a rise of Rs 9.50 or 6.75%. The stock opened at Rs 142.95, moved between Rs 140 and Rs 154, and was trading close to its 52-week high as of 09 October 2026 at 3:22 PM IST. The distance from the day’s high to the current price is small, which keeps Zim Laboratories Share Price in the near-yearly-high zone. On this basis, Zim Laboratories Share Price Update coverage is driven by the verified range, the percentage change and the market-capitalisation backdrop rather than any unverified catalyst.
The latest Univest data confirms the price event, but it does not establish a company-specific reason for the move. For investors searching Zim Laboratories Share News or Zim Laboratories Stock News, the key facts are straightforward: the stock is above the previous close, has stayed well above the day’s low, and remains close to the yearly high. Zim Laboratories Share Price therefore stands out in Stock Market Today discussions as a name moving near a fresh pricing zone.
This makes Zim Laboratories Share Price useful for readers following Share Market Today, Stocks in News and Market Movers, because the price event is clearly defined and time-stamped. Zim Laboratories Share Price Today also remains relevant for those scanning 52 Week High Stocks and Share Price Live updates, since the stock is trading within a narrow band of its one-year high.
Zim Laboratories Ltd. (ZIMLA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 786.1 crore |
| P/E Ratio | 204.2x |
| P/B Ratio | 2.6x |
| ROE | 2.14% |
| ROCE | 5.47% |
| EPS | Rs 0.69 |
| Book Value Per Share | Rs 54.16 |
| Dividend Yield | 0% |
Zim Laboratories Ltd. (ZIMLA) fundamental metrics show P/E 204.2x, P/B 2.6x, ROE 2.14%, ROCE 5.47%. These figures provide context only and are not a buy or sell signal.
Zim Laboratories Ltd. has a market capitalisation of Rs 786.1 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 204.2x, P/B at 2.6x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 2.14% and ROCE of 5.47%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.69, book value per share of Rs 54.16, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.02x, median ROE of 11.61%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 204.2x |
| Benchmark Median P/E | 27.02x |
| Benchmark Average P/E | 39.16x |
| Benchmark P/E Range | 0x to 678.22x |
| Company P/B Ratio | 2.6x |
| Benchmark Median P/B | 2.81x |
| Company ROE | 2.14% |
| Benchmark Median ROE | 11.61% |
| Company ROCE | 5.47% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 786.1 crore |
| Benchmark Median Market Cap | Rs 852.55 crore |
Zim Laboratories Ltd. (ZIMLA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Zim Laboratories Ltd. (ZIMLA) has a P/E ratio of 204.2x, which is above the benchmark median of 27.02x, a difference of +655.74%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Zim Laboratories Ltd. (ZIMLA) has a ROE of 2.14%, which is below the benchmark median of 11.61%, a difference of -81.57%. Zim Laboratories Ltd. (ZIMLA) has a ROCE of 5.47%, which is below the benchmark median of 13.46%, a difference of -59.36%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Amanta Healthcare Ltd. | AMANTA | 761.44 | 51.88 | 3.41 | 9.4 | 11.23 |
| Anuh Pharma Ltd. | ANUHPHR | 821.44 | 18.6 | 2.26 | 12.1 | 16.02 |
| HEXAGON NUTRITION LIMITED | HEXAGON | 883.66 | 22.28 | 3.67 | 18.82 | 22.79 |
| Wanbury Ltd. | WANBURY | 694.62 | 12.14 | 4.63 | 67.87 | 30.31 |
| Kilitch Drugs (India) Ltd. | KILITCH | 895.54 | 28.36 | 3.03 | 12.26 | 14.5 |
Zim Laboratories Ltd. (ZIMLA) has a P/E ratio of 204.2x compared with the displayed peer median of 22.28x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 2.14% compares with a peer median of 12.26% across the companies shown in the table. ROCE stood at 5.47% versus the displayed peer median of 16.02%, providing a capital-efficiency comparison. Zim Laboratories Ltd. (ZIMLA) has a market capitalisation of Rs 786.1 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Zim Laboratories
- Zim Laboratories Share Price is trading at Rs 150.15, above the previous close of Rs 140.65.
- The stock touched Rs 154 during the day, keeping it near its 52-week high.
- Market capitalisation stands at Rs 786.1 crore.
- P/E is 204.2, while P/B is 2.6 and dividend yield is 0.
- ROE is 2.14% and ROCE is 5.47%, both below the same-industry median.
About Zim Laboratories
Zim Laboratories Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. Zim Laboratories Share Price Today is being tracked in the context of that industry classification, the company’s Rs 786.1 crore market capitalisation and the latest quarter revenue of Rs 94.18 crore for Jun 2026. Zim Laboratories Stock News in Univest also places the company alongside other listed names in the same industry, which helps readers compare valuation, returns and market size without adding assumptions beyond the verified figures.
The company profile available for Zim Laboratories Share Price analysis is limited to sector, industry and the financial metrics already discussed. That is still enough to understand why the stock is drawing attention near its 52-week high and why Univest continues to surface it in Share Price Live and Stock Updates screens.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Zim Laboratories Share Price in focus today?
Ans. Zim Laboratories Share Price is in focus because it traded at Rs 150.15, up 6.75% from the previous close, and stayed close to its 52-week high after touching Rs 154 during the day.
What is Zim Laboratories Share Price today?
Ans. Zim Laboratories Share Price today is Rs 150.15. It was above the previous close of Rs 140.65 and remained within reach of the day’s high of Rs 154 as of 09 October 2026 at 3:22 PM IST.
What does the 52-week high event mean for Zim Laboratories Share Price?
Ans. The near 52-week-high event means Zim Laboratories Share Price is trading close to its yearly high, but it has not been stated that the stock set a new high today. The move is price-based and time-stamped.
How has Zim Laboratories Share Price moved compared with the previous close?
Ans. Zim Laboratories Share Price rose Rs 9.50, or 6.75%, from the previous close of Rs 140.65 to Rs 150.15. That places it well above the prior level during the ongoing session.
What is Zim Laboratories market capitalisation?
Ans. Zim Laboratories market capitalisation is Rs 786.1 crore. That places the company below the same-industry median of Rs 852.55 crore, based on the broader Pharmaceuticals & Drugs benchmark set.
What do the valuation metrics show for Zim Laboratories Share Price?
Ans. Zim Laboratories Share Price is backed by a P/E of 204.2 and a P/B of 2.6. The P/E is far above the same-industry median, while the P/B is slightly below it.
How do the profitability ratios compare in Zim Laboratories Share Price analysis?
Ans. Zim Laboratories Share Price is associated with ROE of 2.14% and ROCE of 5.47%. Both figures sit below the same-industry medians of 11.61% and 13.46%, respectively, in the Healthcare benchmark.
What is the book value and EPS for Zim Laboratories Share Price?
Ans. Zim Laboratories Share Price is associated with EPS of Rs 0.69 and book value of Rs 54.16. These figures help place the stock’s valuation in context alongside the current price and industry comparison.
Track Zim Laboratories Share Price on Univest
Use Zim Laboratories Ltd. (ZIMLA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Whether you are scanning Stock Market Today, Share Market Today or Stocks in News, Univest keeps ZIMLA visible with factual updates and company context. For Zim Laboratories Share Price, the near-52-week-high event, sector comparison and fundamental data are all available in a single research-style view.